Navigation Links
Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs
Date:10/13/2008

No interruption to shipments or service to new or existing customers.

BOTHELL, Wash., Oct. 13 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX) announced today that it has initiated a worldwide voluntary field corrective action of certain automated external defibrillators (AEDs) manufactured between August 2006 and March 2007. Some AEDs manufactured in this time frame may have a component whose performance doesn't match the factory software settings. Under a particular set of conditions, the software places the AED into a "Service Required" mode.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

To remedy this and complete the corrective action, Cardiac Science is providing a user-installable software update to affected customers and distributors.

"This voluntary field action is an opportunity for Cardiac Science to demonstrate that we stand behind every one of our products," said John Hinson, chief executive officer.

Cardiac Science has begun notifying distributors and customers with affected devices and is shipping software updates to each. The instructions and additional information regarding the affected units are also available at http://www.cardiacscience.com/AEDUpdate. Customers can also call 1.877.502.2673 or e-mail aedqs99@cardiacsience.com.

Until the updates arrive, customers should keep their AEDs in service. This issue is typically identified in daily self-test, however, there is a remote possibility of occurrence while attempting to provide defibrillation. The Company has received two complaints related to this issue during use.

The company expects to take a pre-tax charge of between $0.8 million and $1.0 million in the third quarter of 2008 relating to the estimated costs associated with this voluntary action. This action will not affect the company's AED manufacturing, shipping schedules, or service support to current or new customers.

"While this unanticipated charge will obviously have an impact on third quarter earnings, we presently expect that we will still finish the full year within the range of our earlier guidance, though we are now more comfortable with the lower end of that range," said Mike Matysik, chief financial officer. Cardiac Science expects to announce its third quarter 2008 results in late October and will provide an update on guidance for the balance of the year at that time.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, those that refer to full-year guidance for Cardiac Science Corporation's future revenue and profits. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2007. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For more information,

Company Contact: Investor Contact: Media Contact:

Mike Matysik Doug Sherk Christopher Gale

Cardiac Science Jenifer Kirtland EVC Group, Inc.

Corporation EVC Group, Inc. (201) 646-5431

Sr. Vice President (415) 896-6820 (203) 570-4681

and CFO cgale@evcgroup.com

(425) 402-2009 CSCX-G


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques
2. 3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
3. Ganatra Family Gift to Boost Cardiac Technology at Levine Childrens Hospital
4. New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest
5. UHN becomes a world leader in medical imaging for stroke, cancer and cardiac patients
6. Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures
8. Making Sudden Cardiac Arrest a National Health Priority: National Medical Association Issues White Paper on Sudden Cardiac Arrest
9. Freescale and Monebo Launch ECG-on-a-Chip Platform Solution to Aid Heart Monitoring : Advanced Hardware and Software Technology Designed to Enable More Efficient and Higher Quality Cardiac Care
10. ELS Plus CPR Boosts Blood Flow After Cardiac Arrest
11. Screening Athletes Could Cut Sudden Cardiac Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: